+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Altimmune Announces Clinical Program Updates And Plans For Pipeline Expansion is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Press Release Altimmune Announces Clinical Program Updates And Plans For Pipeline Expansion | RobinsPost News & Noticias

Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results


Body composition study showed lean mass preservation, with only 25.5% of weight loss derived from lean massEnrollment ongoing in IMPACT Phase 2b ... Read More

BioVie Announces Pipeline Update and Near-Term Clinical Priorities


“Prioritizing the Parkinson’s program ... press release contains forward-looking statements, which may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan ... Read More

Fusion Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Clinical Program Updates


We expect to provide an update on this program around mid-year 2024. Underpinning our platform, which has produced a robust pipeline of ... Statements This press release contains "forward-looking ... Read More

Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome


The decisions follow IDMC review of available clinical data from the patients dosed with TSHA-102. The Company also announced the expansion of its ongoing ... please visit www.tayshagtx.com. This ... Read More

News, Updates, & Press Releases


While the biomass industry has hit a rocky patch with the recent news that Enviva, the world's largest biomass producer, filed for Chapter 11 bankruptcy, the Department of Energy thinks the U.S ... Read More

Neurogene Announces Expansion and Plans for More Rapid Patient Enrollment of Rett Syndrome Gene Therapy Clinical Trial


today announced the expansion of its ongoing Phase 1/2 gene therapy clinical trial for NGN-401 for female pediatric patients with Rett syndrome and updates to enable more rapid enrollment in the ... Read More

BioVie Announces Pipeline Update and Near-Term Clinical Priorities


Phase 3 trial for BIV201 in preparation following FDA feedback with guidance on development path; program ... press release contains forward-looking statements, which may be identified by words such ... Read More

Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome


Update on available clinical data from completed cohort one of 5.7x1014 total vg expected in the first quarter of 2024. Dosing of the first patient in cohort two (high dose, n=3) of 1x1015 total ... Read More

BioVie Announces Pipeline Update and Near-Term Clinical Priorities


Recently completed financing provides sufficient funds for near-term Parkinson’s Disease priority Plans for Phase 2b trial of NE3107 as first-line monotherapy for Parkinson’s Disease being ... Read More

Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome


The decisions follow IDMC review of available clinical data from the patients dosed with TSHA-102. The Company also announced the expansion ... This press release contains forward-looking ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus